More recently, it was demonstrated that monocytic MDSCs in patients with bladder cancer, in contrast to healthy donors, frequently co-express membrane-bound enzyme hyaluronidase 2 (Hyal2). Here, HYAL2 is linked to urinary bladder carcinoma.